Moody’s Analytics Announces Cloud Services to Help Banks with Regulatory Compliance
Moody’s Analytics has enhanced its software and service offerings for the banking industry by making its regulatory compliance and balance sheet management solutions available on the cloud.
Building on its existing cloud-enabled and software-as-a-service (SaaS) solutions, this latest development comes at a time when banks are increasingly considering cloud-based and SaaS solutions as a way to reduce costs, improve speed of operations, and extract more value from back-office and middle-office systems.
Solutions now available on the cloud include the Moody’s Analytics RiskAuthority™ platform, RiskConfidence™ ALM and Impairment system, Regulatory Reporting Module, RiskFoundation™ Discovery solution, and Scenario Analyzer. The cloud-enabled solutions can be deployed in public, private, or hybrid cloud environments, and cover various regulatory requirements and accounting standards, such as IFRS 9, CECL, ALM/IRRBB, and Basel I, II, and III. These solutions also address stress testing under the Dodd-Frank Act Stress Testing (DFAST) rules, Comprehensive Capital Analysis and Review (CCAR), and the European Banking Authority’s (EBA) rules.
“As banks look for ways to conduct business faster and more cost effectively, they seek a cloud-first approach to regulatory technology that enables them to have all of their solutions on a single platform,” said Andrew Bockelman, Managing Director at Moody’s Analytics. “Our objective is to empower banks that are implementing regulatory technology with a world-class cloud platform powered by our award-winning regulatory solutions.”
For clients that want a fully cloud-native technology stack, Moody’s Analytics is also launching the first of several new cloud-optimized SaaS offerings on Amazon Web Services (AWS). The first regulatory reporting SaaS solution will address the ECB’s AnaCredit regulatory reporting requirements. It will offer a hosted, flexible, and scalable regulatory solution to help financial institutions in the eurozone produce the required ECB AnaCredit reports.
“In moving forward with our cloud strategy, we are launching a new generation of products that are fully optimized for the cloud,” added Bockelman. “These solutions feature enhanced business intelligence, data management, and industry-leading reporting tools.”
Click here to learn more about Moody’s Analytics regulatory technology solutions.
About Moody’s Analytics
Moody’s Analytics provides financial intelligence and analytical tools supporting our clients’ growth, efficiency, and risk management objectives. The combination of our unparalleled expertise in risk, expansive information resources, and innovative application of technology helps today’s business leaders confidently navigate an evolving marketplace. We are recognized for our industry-leading solutions, comprising research, data, software and professional services, assembled to deliver a seamless customer experience. Thousands of organizations worldwide have made us their trusted partner because of our uncompromising commitment to quality, client service, and integrity.
Moody's Analytics is a subsidiary of Moody's Corporation (NYSE: MCO). MCO reported revenue of $4.2 billion in 2017, employs approximately 11,900 people worldwide and maintains a presence in 41 countries. Further information about Moody’s Analytics is available at www.moodysanalytics.com.
Moody’s Analytics Communications
Tracey Scott, 044.207.772.5207
Moody’s Analytics Media Relations
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
NEC Iris Recognition Technology Ranks First in NIST Accuracy Testing27.4.2018 05:00 | Tiedote
NEC Corporation (NEC) (TOKYO: 6701) today announced that its iris recognition technology achieved the highest matching accuracy evaluation in the recent Iris Exchange (IREX,*1) IX evaluations of automated iris recognition algorithms performed by the U.S. National Institute of Standards and Technology (NIST). Iris recognition technology is a biometrics identifier that uses patterns from the iris, the donut-like tissue that surrounds the pupil. In recent years, this technology has been adopted by systems that require large-scale matching, mainly for organizations and companies, since it is possible to quickly provide highly accurate authentication with devices that do not require physical contact. From the standpoint of privacy protection and security enhancement, government agencies in particular are in growing need of reliable personal authentication for purposes that include citizen ID, immigration control and criminal investigations. NEC received the top accuracy ranking in the IREX
Gemalto First Quarter 2018 Revenue27.4.2018 01:00 | Tiedote
Regulatory News: Gemalto (Euronext NL0000400653 - GTO), the world leader in digital security today announces its revenue for the first quarter of 2018. Revenue (€ in millions) First quarter 2018 First quarter 2017 Change at constant exchange rates Change at historical exchange rates Identity, IoT & Cybersecurity 293 256 +24% +15% Smartcards & Issuance 357 396 (2%) (10%) Total 650 651 +8% = Philippe Vallée, Chief Executive Officer, commented: “Gemalto grew well this quarter driven by a solid increase in the Identity, IoT & Cybersecurity segment that more than offset the anticipated revenue decrease in the Smartcards & Issuance segment. During the quarter, commercial synergies with the newly acquired Identity Management business began to kick in and resulted in milestone wins in Governments. Gemalto also announced the launch of two ground-breaking laser-personalized innovations designed to significantly increase the security of passports and IDs. The Cybersecurity business grew well in E
Elliott Advisors (UK) Limited Statement on Telecom Italia26.4.2018 22:49 | Tiedote
Elliott Advisors (UK) Limited (“Elliott”) today sent a new letter and a presentation to Telecom Italia (“TIM” or the “Company”) shareholders calling upon shareholders to uphold best practice governance principles at TIM’s upcoming shareholder meeting on May 4th. Inadequate governance and poor stewardship have imposed a heavy cost on TIM’s stakeholders for too long. Vivendi’s repeated missteps and self-serving behaviour have eroded the value of TIM’s shares and destroyed shareholder trust. The question being put to TIM shareholders on May 4th is: can you entrust your investment to Vivendi as long-term stewards of your capital and this company moving forward? Shareholders should take the opportunity to correct a governance structure rife with conflict and demand high quality and independent stewardship at the Board level. Shareholders have the opportunity to remove an otherwise permanent, persisting and pervasive impairment of value. This pivotal vote offers a textbook opportunity to put
Javier Gómez Noya Chooses ROKA Eyewear26.4.2018 21:15 | Tiedote
ROKA, the Austin-based performance design company, has announced a multiyear eyewear partnership with eight-time triathlon world champion and Olympic silver medalist Javier Gómez Noya, expanding their existing relationship for technical race apparel and equipment. Starting in 2018, Gómez will train and race in ROKA’s eyewear, the lightest, most advanced performance optics in the world, in the pursuit of his first Ironman World Championship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180426006510/en/ Javier Gómez Noya Chooses ROKA Eyewear (Photo: Business Wire) “I first tried the Advanced Performance eyewear while I was at ROKA’s headquarters in Texas, and right away I knew they were the glasses I should be using everyday,” Gómez Noya says. “There’s nothing like them in terms of weight, retention, and quality of vision. Whether cycling or running, you can’t feel that you’re wearing them but you have an incredible field of
Egyptian Singer Becomes First Woman to Perform Before a Mixed Crowd in Saudi Arabia26.4.2018 20:55 | Tiedote
History was made in Saudi Arabia on Wednesday as a female singer performed before a mixed audience for the first time in the country. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180426006471/en/ Egypt’s National Arab Music Ensemble of the Egyptian Opera House debuted in Saudi Arabia with the singer Nihad Fathy performing before a 2,500-strong audience in Riyadh. This is the first time a woman singer performed on stage in the Kingdom before a mixed crowd. (Photo courtesy of GCA Saudi Arabia.) Egypt’s National Arab Music Ensemble (AME) of the Egyptian Opera House debuted in the Kingdom with the singer Nihad Fathy performing before a 2,500-strong audience at King Fahad Cultural Center in Riyadh. The crowd broke into a rapturous applause as she took to the stage. The Egyptian Opera House ensemble, which was led by famous conductor Moustafa Helmy, comprised 45 male and female musicians and singers, including the star singers A
Pharnext Appoints Amit Kohli as Chief Operating Officer26.4.2018 19:00 | Tiedote
Regulatory News: Pharnext SA (Paris:ALPHA) (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big genomic data and artificial intelligence, today announced the appointment of Amit Kohli, a senior healthcare industry executive, as Chief Operating Officer (COO). Mr. Kohli is responsible for leading Pharnext’s corporate strategy and operations. “Amit is a seasoned leader with over 20 years’ experience in the healthcare industry, and we are thrilled he is joining Pharnext,” said Prof. Daniel Cohen, M.D., Ph.D., Co-Founder and Chief Executive Officer of Pharnext. “We are deeply impressed with Amit’s results-oriented track record, and his ability to drive business strategy and operations across the pharma, medtech and clinical diagnostics sectors. We believe Pharnext will greatly benefit from his extensive cross-functional leadership experience especially as our first-in-class orphan drug, PXT3003, for the
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme